Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure 2 from Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade–resistant Melanoma for Anti-PD-L1 Rechallenge
  1. Home
  2. Publications
  3. Supplementary Figure 2 from Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade–resistant Melanoma for Anti-PD-L1 Rechallenge

Supplementary Figure 2 from Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade–resistant Melanoma for Anti-PD-L1 Rechallenge

Authors:
  • AWAndre van der Westhuizen
    Andre van der Westhuizen
  • MLMegan Lyle
    Megan Lyle
  • MGMoira C. Graves
    Moira C. Graves
  • Xiaoqiang Zhu
    Xiaoqiang Zhu
  • JWJason W. H. Wong
    Jason W. H. Wong
  • KCKerrie Cornall
    Kerrie Cornall
  • SRShu Ren
    Shu Ren
  • LPLeanna Pugliese
    Leanna Pugliese
  • RLRichard Levy
    Richard Levy
  • AMAdeeb Majid
    Adeeb Majid
  • RVRicardo E. Vilain
    Ricardo E. Vilain
  • NBNikola A. Bowden
    Nikola A. Bowden

Open Access
Publisher website
Google Scholar
  • 4 April 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.22545465.v1
Abstract
No abstract available
Keywords
  • CARBOPLATIN
  • REPURPOSING
  • IMMUNE CHECKPOINT
  • AZACITIDINE
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.